Issues

2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 - 11 - 12 - 13 - 14 - 15 - 16 - 17 - 18 - 19 - 20 - 21 - 22 - 23 - 24 -

25 - 26 - 27 - 28

SURGICAL TECHNOLOGY INTERNATIONAL III.

Sections

$175.00

 

STI III contains 60 articles with color illustrations.

 

Universal Medical Press, Inc.

San Francisco, 1994, ISBN: 0-9643425-1-0

 

Order STI III - View Cart

 

 

 

 

 

 

 

 ┬╗

 

 

Neurosurgery

 

No Access Surgery: The Gamma Knife
L. Dade Lunsford, M.D., Douglas Kondziolka, M.D., F.R.C.S.(C), John C. Flickinger, M.D., University of Pittsburg Medical Center, Pittsburgh, PA

 

Abstract

Swedish neurosurgeon Lars Leksell, frustrated by the invasiveness of existing surgical tools and the morbidity some neurosurgical patients endured, created the field of stereotactic radiosurgery in 1951.1,2 He subsequently pioneered the development of the dedicated multi-source Cobalt 60 Gamma Knife®. During the 27 year interval from its first clinical use in 1967 to its latest application in 1994-, single fraction, closed skull irradiation of deep intracranial targets has been performed in more than 20,000patients worldwide. The goals of radiosurgery are obliteration or prevention of further growth of the target coupled with reduced patient risk in comparison to more invasive procedures.

Order Article by e-mail:

PDF Format - $69.00

 

Order Article Reprint

Copies:  500 - $1,960.00

- 1000 - $3,720.00

- 3000 - $6,475.00

 

Human Brain Grafting: An Approach to the Treatment of Neurodegenerative Diseases
Ignacio Madrazo, M.D., D.Sc., Hugo Castrejon, M.D., Centro Medico National Siglo XXI, Instituto Mexicano del Seguro Social, Mexico D.F., Mexico, Rebecca E. Franco-Bourland, Ph.D., Instituto Nacional de la Nutricion Salvador Zubiran, Mexico, D.F., Mexico

 

Abstract

The aim of human brain grafting is to deliver adequate amounts of endocrine or neural tissue to neurodegenerated areas of the diseased or lesioned brain for functional recovery. The many options available make brain grafting and other neural grafting procedures potentially applicable for the treatment of varied alterations of the central nervous system, such as Parkinson's disease (PD), Huntington's disease (HD), Alzheimer's disease, epilepsy, amyotrophic lateral sclerosis, spinal cord lesions, assorted traumatic lesions to the central nervous system, stroke, etc.

Order Article by e-mail:

PDF Format - $69.00

 

Order Article Reprint

Copies:  500 - $1,960.00

- 1000 - $3,720.00

- 3000 - $6,475.00